Multiple sclerosis drug mitoxantrone may be linked to increased risk of colorectal cancer

Posted by on May 11, 2016 8:25 pm
Tags:
Categories: health

The multiple sclerosis (MS) drug mitoxantrone may be associated with an increased risk of colorectal cancer, according to a study. Mitoxantrone suppresses the immune system. It was first developed as a chemotherapy drug for certain cancers.

Leave a Reply

Your email address will not be published. Required fields are marked *